GBR-13069
Glycogen Storage Disease Type I[edit | edit source]
Glycogen Storage Disease Type I (GSD I), also known as von Gierke disease, is a metabolic disorder characterized by the accumulation of glycogen in the liver and kidneys due to a deficiency in the enzyme glucose-6-phosphatase. This enzyme is crucial for the final step of gluconeogenesis and glycogenolysis, which is the conversion of glucose-6-phosphate into free glucose.
Pathophysiology[edit | edit source]
GSD I is caused by mutations in the G6PC gene, which encodes the glucose-6-phosphatase enzyme. The deficiency of this enzyme leads to the inability to convert glucose-6-phosphate into glucose, resulting in the accumulation of glycogen and fat in the liver and kidneys. This accumulation causes hepatomegaly and nephromegaly, and the inability to maintain normal blood glucose levels leads to hypoglycemia.
Clinical Features[edit | edit source]
Patients with GSD I typically present in infancy with symptoms such as severe hypoglycemia, lactic acidosis, hyperuricemia, and hyperlipidemia. The hypoglycemia can lead to seizures and developmental delay if not managed properly. Other features include a "doll-like" facial appearance, short stature, and delayed puberty.
Diagnosis[edit | edit source]
The diagnosis of GSD I is based on clinical presentation, biochemical tests, and genetic testing. Biochemical tests reveal hypoglycemia, lactic acidosis, hyperuricemia, and hyperlipidemia. Genetic testing can confirm mutations in the G6PC gene.
Management[edit | edit source]
Management of GSD I focuses on maintaining normal blood glucose levels to prevent hypoglycemia. This is achieved through frequent feedings of cornstarch and a high-carbohydrate diet. In some cases, allopurinol is used to manage hyperuricemia, and lipid-lowering agents may be used to control hyperlipidemia.
Prognosis[edit | edit source]
With proper management, individuals with GSD I can lead relatively normal lives, although they may have an increased risk of developing hepatic adenomas and renal disease later in life.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD